| Abstrakt: |
A study conducted at New York Presbyterian Hospital explores the use of hybrid PET/MRI imaging for somatostatin receptor-expressing tumors in the head and neck region. The combination of PET and MRI provides improved lesion localization, disease extent demonstration, surveillance enhancement, radiation therapy planning optimization, and response prediction to somatostatin analog therapy. Radiologists are advised to be aware of the benefits and potential challenges of somatostatin receptor PET/MRI for evaluating head and neck tumors. This research has been peer-reviewed and offers valuable insights into the diagnostic capabilities of this imaging approach. [Extracted from the article] |
